Skip to content
  • Friday, 14 August 2026
  • 11:25 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Texas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative Decline
Neuroscience & Brain Research

Texas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative Decline

Rifan Muazin Jun 3, 2026 0

In a significant advancement for regenerative medicine and neurology, a research team at Texas A&M University has unveiled a novel…

Read More
Neuroscience & Brain Research

Texas A&M Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Cognitive Decline

Rifan Muazin May 27, 2026 0

In a significant advancement for regenerative medicine, a team of scientists at Texas A&M University has developed an experimental nasal…

Read More
Pharmaceutical R&D

Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure

Teuku Ryan May 9, 2026 0

Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…

Read More
Unveiling Earth’s Hidden Infrastructure: First Global Maps Detail Vast Underground Fungal Networks Essential for Climate RegulationWhat if psilocybin works about as well for depression as an SSRI?University of Helsinki Researchers Uncover Novel Intracellular Oxygen Exchange Mechanism in PlantsAre AI Agents Your Next Security Nightmare?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ